Importantly, monitoring of GC-B activity in atherosclerotic plaques using real-time cGMP imaging and the genetic LacZ reporter indicated that phenotypic modulation of VSMCs that occurs during the progression of atherosclerosis leads to the development of GC-B positive plaque cells in vivo (Figs. 5, 6). The gene discussed is NPR2; the disease is atherosclerosis.